ADC Therapeutics (ADCT) EBIT (2023 - 2026)
ADC Therapeutics' (ADCT) quarterly EBIT came in at -$25.2 million in Q1 2026, up 11.31% year-on-year from -$22.7 million in Q1 2025, and up 18.48% quarter-over-quarter from -$31.0 million in Q3 2025.
ADC Therapeutics (ADCT) EBIT (2023 - 2026) Analysis & Trends
ADC Therapeutics has disclosed EBIT across 4 years of filings, most recently posting -$25.2 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -15.76 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -65.83 Mn |
| 10 | ADC Therapeutics | 167.24 Mn | -63.76 Mn | 7.33 Mn | -25.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.25 Mn |
| Sep 30, 2025 | -30.97 Mn |
| Jun 30, 2025 | -44.15 Mn |
| Mar 31, 2025 | -28.46 Mn |
| Sep 30, 2024 | -35.56 Mn |
| Jun 30, 2024 | -29.04 Mn |
| Mar 31, 2024 | -33.61 Mn |
| Sep 30, 2023 | -36.15 Mn |
| Jun 30, 2023 | -39.65 Mn |